Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (26,451)	$ (95,255)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,279	1,487
Loss from PIK Note Amendment and 2022 Debenture Release	3,521
Impairment charges	2,633	1,370
Equity-based compensation	381	11,035
Cantor commitment fee paid in common stock		1,600
Loss on settlement of the forward purchase agreement paid in common stock		270
Release of forward purchase agreement collateral upon cancellation		26,773
Vendor share issuance paid in common stock		376
Amortization of consulting fees paid in common stock	2,221	4,679
Common stock issued and issuable under Shares for Services Agreements	865
Change in fair value of convertible debentures		28,180
Change in fair value of warrants	(303)	(2,076)
Conversion of accrued interest		593
PIK interest	616	130
Amortization of debt issuance costs	448	91
Contributions in the form of rent payments		225
Amortization of right-of-use assets		28
Accretion of operating lease liabilities		(28)
Recognition of prepaid offering costs upon election of fair value option		107
Other	125	6
Changes in operating assets and liabilities:
Supplies	1,313	(1,018)
Prepaid expenses and consulting fees	3,055	(2,832)
Other current assets	5	(91)
Other assets		(100)
Cloud computing arrangements		(1,773)
Reinsurance recoverables	18,573	890
Accounts payable	1,297	127
Accrued and other liabilities	2,350	2,336
Policy reserves	(18,573)	(890)
Net cash used in operating activities	(6,645)	(23,760)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment		(110)
Development of internal use software		(1,760)
Net cash used in investing activities		(1,870)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of convertible debentures		28,000
Warrant repurchase		(507)
Senior PIK Notes proceeds		3,458
Reverse recapitalization proceeds		23,237
Forward purchase agreement		(30,561)
Forward purchase agreement collateral release		2,362
Private placements	1,176
Deferred offering costs	(299)	(540)
Related parties promissory notes/payables	291	(1,160)
Net cash provided by financing activities	1,168	24,289
Net change in cash and cash equivalents	(5,477)	(1,341)
Cash and cash equivalents at beginning of period	5,515	6,856
Cash and cash equivalents at end of period	38	5,515
NONCASH INVESTING AND FINANCING ACTIVITIES:
Conversion of debt		88,382
Deemed dividends related to the Exchange Offer and trigger of down round provisions of Assumed Warrants	3,378
PIK Note Amendment	1,339
2022 Debenture Release	2,182
Conversion of preferred stock		21,854
Accrued internal use software		239
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest, net of amounts capitalized		1,219
Cash paid for income taxes